scispace - formally typeset
J

Jan H.M. Tordoir

Researcher at Maastricht University Medical Centre

Publications -  169
Citations -  9359

Jan H.M. Tordoir is an academic researcher from Maastricht University Medical Centre. The author has contributed to research in topics: Arteriovenous fistula & Hemodialysis. The author has an hindex of 46, co-authored 164 publications receiving 8582 citations. Previous affiliations of Jan H.M. Tordoir include Maastricht University.

Papers
More filters
Journal ArticleDOI

Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate.

TL;DR: Although, the autogenous RCAVF is considered to be the primary choice for vascular access, this meta-analysis indicates a high primary failure rate and only moderate patency rates at 1 year of follow-up.
Journal ArticleDOI

EBPG guideline on haemodynamic instability

TL;DR: The patient has a history of undiagnosed central giant cell granuloma, and the treatment of IDH and antihypertensive drugs and preventive medication was determined to be safe and effective.
Journal ArticleDOI

Upper extremity ischemia and hemodialysis vascular access.

TL;DR: Augmentation of arterial inflow by interventional techniques and/or AVF bloodflow-reducing surgical procedures may eliminate pain and heal ulcers, and the best results are obtained by bypassing the arteriovenous anastomotic site and interruption of steal phenomenon by ligation of the artery distal to the AVAnastomosis.
Journal ArticleDOI

EBPG guideline on dialysis strategies

TL;DR: Department of Renal Medicine, St James’s University Hospital, Leeds, UK, Nephrology Department, Reina Sofia University hospital, Cordoba, Spain, Division of Nephrology and Dialysis, Bolognini Hospital, Seriate, Italy.
Journal ArticleDOI

Intimal Hyperplasia in Vascular Grafts

TL;DR: Intimal hyperplasia is now recognised as the main cause of thrombotic complications occurring between 2 and 24 months after compliance mismatch, and some solutions have had promising results with respect to improved pata vascular intervention.